Steve Kirsch's newsletter
Steve KirschI write about COVID mitigation policies, vaccines, corruption, censorship, and early treatments. The data shows that vaccines are ruining the health of Americans and driving the epidemic in a variety of health conditions.
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 1658 | Subscribers | Read | kirschsubstack.com |
Curious about how many subscribers Steve Kirsch's newsletter has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #7 | |
| #8 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
COVID vaccine injury study published on preprint server because the mainstream medical journals refused to publish it
The Yale LISTEN study points out that 42 people with post-vaccination syndrome (PVS) have a large number of differences in common compared to 22 people who got the COVID shots and who didn’t develop problems.
MAHA Alliance press conference video: "We will never do that study" -- Tony Fauci
Del Bigtree’s talk at 37 minutes is not to be missed. He says the NIH (Collins and Fauci) told RFK and Del in 2017 that the NIH would NEVER do a retrospective comparison study in the VSD database between the vaccinated and unvaccinated.
VSRF LIVE TONIGHT: Episode 164 - White Clot Roundtable!
Join us tonight for an exclusive and in-depth VSRF LIVE as we host the White Clot Roundtable – a groundbreaking conversation about the shocking phenomenon of white fibrous clots and micro-clotting found in cadavers around the world.
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
Founder, Vaccine Safety Research Foundation (vacsafety.org)
Frequently Asked Questions
How can I access the email archive for Steve Kirsch's newsletter?
You can find recent issues that have been published by Steve Kirsch's newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Steve Kirsch's newsletter have?
To see how many people subscribe to Steve Kirsch's newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Steve Kirsch's newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Steve Kirsch's newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Steve Kirsch's newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Steve Kirsch's newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Steve Kirsch's newsletter?
Scroll up to where it says Similar Newsletters to see other publications like Steve Kirsch's newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Steve Kirsch's newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.